Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The term of End Stage of Liver Disease (ESLD) was raised in 80's of 20 Century, but without a restrict definition. Infections are the cause and effect in occurrence and development of ESLD, which not only induce or exacerbate ESLD, but also are the most combined complication. Multi-resistant bacteria, multi-organ injury, selection of anti-microbes, supporting treatment, disorder of intestine microbiota, et al are dilemma in clinical practice. Appropriate and formal diagnosis and treatment of ESLD combined infection are imperious nowadays.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Infection Group | Patients with end stage liver disease with infection |
| |
| Non-infection Group | Patients with end stage liver disease without infection |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Antibiotics | Drug | This is an observation study, no specific antibiotics will be indicated during treatment |
|
| Measure | Description | Time Frame |
|---|---|---|
| Complete response rate to empirical antibiotic treatment | The percentage of patients who achieved complete recovery from combined infection after empirical antibiotic treatment | 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Non-liver transplant survival | Non-liver transplant survival rate at 30 days, 60 days and 6 months after empirical antibiotic treatment | 6 months |
| Hospitalization time | Days of hospitalization after empirical antibiotic treatment |
Not provided
Inclusion Criteria:
Decompensation of liver cirrhosis:
Acute-on-chronic liver failure:
Chronic liver failure:
Exclusion Criteria:
-
Not provided
Not provided
Not provided
Not provided
Patients with chronic liver disease
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Department of Infectious Disease, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology | Recruiting | Wuhan | Hubei | 430030 | China |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D058625 | End Stage Liver Disease |
| D007239 | Infections |
| ID | Term |
|---|---|
| D017093 | Liver Failure |
| D048550 | Hepatic Insufficiency |
| D008107 | Liver Diseases |
| D004066 | Digestive System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000900 | Anti-Bacterial Agents |
| ID | Term |
|---|---|
| D000890 | Anti-Infective Agents |
| D045506 | Therapeutic Uses |
| D020228 | Pharmacologic Actions |
| D020164 | Chemical Actions and Uses |
Not provided
Not provided
Not provided
Not provided
Not provided
| 6 months |